Vitrolife AB (VTRLY) Q2 2026 Earnings Call Highlights: Record Revenue and Strategic Challenges

Vitrolife AB (VTRLY) reports strong growth in the Americas and successful product launches, but faces regional challenges impacting overall performance. Related Stocks: VTRLY